These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 33991530)
41. [Molecular mechanisms of iron homeostasis]. Beaumont C Med Sci (Paris); 2004 Jan; 20(1):68-72. PubMed ID: 14770366 [TBL] [Abstract][Full Text] [Related]
42. Iron metabolism: State of the art. Daher R; Karim Z Transfus Clin Biol; 2017 Sep; 24(3):115-119. PubMed ID: 28694024 [TBL] [Abstract][Full Text] [Related]
43. [Expression Changes of Hepcidin and Ferroportin 1 in Murine Model of Iron Overload]. Wang JW; Xu LH; Yao X; Fang JP Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):936-940. PubMed ID: 28641663 [TBL] [Abstract][Full Text] [Related]
44. Bone marrow iron distribution, hepcidin, and ferroportin expression in renal anemia. Bârsan L; Stanciu A; Stancu S; Căpuşă C; Brătescu L; Mandache E; Radu E; Mircescu G Hematology; 2015 Oct; 20(9):543-52. PubMed ID: 25745821 [TBL] [Abstract][Full Text] [Related]
45. Physiological focus on the erythropoietin-hepcidin-ferroportin axis. D'Anna MC; Roque ME Can J Physiol Pharmacol; 2013 May; 91(5):338-45. PubMed ID: 23656253 [TBL] [Abstract][Full Text] [Related]
46. Hepatic hepcidin/intestinal HIF-2α axis maintains iron absorption during iron deficiency and overload. Schwartz AJ; Das NK; Ramakrishnan SK; Jain C; Jurkovic MT; Wu J; Nemeth E; Lakhal-Littleton S; Colacino JA; Shah YM J Clin Invest; 2019 Jan; 129(1):336-348. PubMed ID: 30352047 [TBL] [Abstract][Full Text] [Related]
47. Deciphering the molecular basis of ferroportin resistance to hepcidin: Structure/function analysis of rare SLC40A1 missense mutations found in suspected hemochromatosis type 4 patients. Le Tertre M; Ka C; Guellec J; Gourlaouen I; Férec C; Callebaut I; Le Gac G Transfus Clin Biol; 2017 Nov; 24(4):462-467. PubMed ID: 28826751 [TBL] [Abstract][Full Text] [Related]
48. Iron metabolism and iron disorders revisited in the hepcidin era. Camaschella C; Nai A; Silvestri L Haematologica; 2020; 105(2):260-272. PubMed ID: 31949017 [TBL] [Abstract][Full Text] [Related]
49. Iron Availability in Tissue Microenvironment: The Key Role of Ferroportin. Gammella E; Correnti M; Cairo G; Recalcati S Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804198 [TBL] [Abstract][Full Text] [Related]
50. Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease. Zoller H; McFarlane I; Theurl I; Stadlmann S; Nemeth E; Oxley D; Ganz T; Halsall DJ; Cox TM; Vogel W Hepatology; 2005 Aug; 42(2):466-72. PubMed ID: 15986403 [TBL] [Abstract][Full Text] [Related]
51. Icariin regulates systemic iron metabolism by increasing hepatic hepcidin expression through Stat3 and Smad1/5/8 signaling. Zhang M; Liu J; Guo W; Liu X; Liu S; Yin H Int J Mol Med; 2016 May; 37(5):1379-88. PubMed ID: 27035325 [TBL] [Abstract][Full Text] [Related]
52. Hepcidin in Iron Homeostasis: Diagnostic and Therapeutic Implications in Type 2 Diabetes Mellitus Patients. Ambachew S; Biadgo B Acta Haematol; 2017; 138(4):183-193. PubMed ID: 29136618 [TBL] [Abstract][Full Text] [Related]
53. Deregulation of proteins involved in iron metabolism in hepcidin-deficient mice. Viatte L; Lesbordes-Brion JC; Lou DQ; Bennoun M; Nicolas G; Kahn A; Canonne-Hergaux F; Vaulont S Blood; 2005 Jun; 105(12):4861-4. PubMed ID: 15713792 [TBL] [Abstract][Full Text] [Related]
54. Hepcidin-mediated hypoferremic response to acute inflammation requires a threshold of Bmp6/Hjv/Smad signaling. Fillebeen C; Wilkinson N; Charlebois E; Katsarou A; Wagner J; Pantopoulos K Blood; 2018 Oct; 132(17):1829-1841. PubMed ID: 30213871 [TBL] [Abstract][Full Text] [Related]
55. Molecular pathogenesis of hereditary hemochromatosis. Liu J; Pu C; Lang L; Qiao L; Abdullahi MA; Jiang C Histol Histopathol; 2016 Aug; 31(8):833-40. PubMed ID: 27031690 [TBL] [Abstract][Full Text] [Related]
56. Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus-infected liver. Kohjima M; Yoshimoto T; Enjoji M; Fukushima N; Fukuizumi K; Nakamura T; Kurokawa M; Fujimori N; Sasaki Y; Shimonaka Y; Murata Y; Koyama S; Kawabe K; Haraguchi K; Sumida Y; Harada N; Kato M; Kotoh K; Nakamuta M World J Gastroenterol; 2015 Mar; 21(11):3291-9. PubMed ID: 25805936 [TBL] [Abstract][Full Text] [Related]
57. Upregulation of iron regulatory hormone hepcidin by interferon α. Ichiki K; Ikuta K; Addo L; Tanaka H; Sasaki Y; Shimonaka Y; Sasaki K; Ito S; Shindo M; Ohtake T; Fujiya M; Torimoto Y; Kohgo Y J Gastroenterol Hepatol; 2014 Feb; 29(2):387-94. PubMed ID: 23926964 [TBL] [Abstract][Full Text] [Related]
58. Genetic background influences hepcidin response to iron imbalance in a mouse model of hemolytic anemia (Congenital erythropoietic porphyria). Lefebvre T; Millot S; Richard E; Blouin JM; Lalanne M; Lamrissi-Garcia I; Costet P; Lyoumi S; Gouya L; Puy H; Moreau-Gaudry F; de Verneuil H; Karim Z; Ged C Biochem Biophys Res Commun; 2019 Dec; 520(2):297-303. PubMed ID: 31601421 [TBL] [Abstract][Full Text] [Related]
59. Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin. Aschemeyer S; Qiao B; Stefanova D; Valore EV; Sek AC; Ruwe TA; Vieth KR; Jung G; Casu C; Rivella S; Jormakka M; Mackenzie B; Ganz T; Nemeth E Blood; 2018 Feb; 131(8):899-910. PubMed ID: 29237594 [TBL] [Abstract][Full Text] [Related]
60. In-depth review: is hepcidin a marker for the heart and the kidney? Afsar RE; Kanbay M; Ibis A; Afsar B Mol Cell Biochem; 2021 Sep; 476(9):3365-3381. PubMed ID: 33942218 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]